Two new guidelines have many clinicians, newscasters, and patients talking.
This Continuing Education activity is supported by an independent educational grant from Nature Made Nutritional Products.
As models for payment evolve, it's important to consider the best interests of the patient.
A new trend is emerging as health system–based specialty pharmacies become a staple in the industry.
Proton pump inhibitors are cost-effective options for stress ulcer prophylaxis.
In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.
The antihyperglycemic therapeutic class will continue to be a major contributor to prescription drug trends in 2011 and beyond.
A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
As one of Academy of Managed Care Pharmacy’s two annual conventions, AMCP Nexus aims to provide in-depth educational programming on the current advances and challenges in managed care.
In outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.
Our research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.
Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
An automated reinforcement platform was shown to increase statin adherence by 34.6%.
The oncology pharmaceutical market is rapidly growing and changing.
As Pharmacy Times® goes to press this month, there is a lot of encouraging news on the coronavirus 2019 (COVID-19) front.
The perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.
Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
The increasing prevalence of oral oncolytics use, further accelerated by COVID-19, heightens the need for strong patient-pharmacist treatment coordination.
Adherence for targeted therapies is even more essential now than it ever has been. This case study of services offered at a specialty pharmacy illustrates the impact of hepatitis C patients.
Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
As we shift the healthcare paradigm, new ways to lower costs and improve adherence are worth another look.
Among the commercially insured, pharmacy benefits define the availability, accessibility, and cost of prescription drugs.
Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.